These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 30187963)

  • 1. Neonatal urticaria: Could it be CAPS?
    Cutts L; Parslew R; Eustace K
    Pediatr Dermatol; 2018 Nov; 35(6):e420-e421. PubMed ID: 30187963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cryopyrin-associated periodic syndromes].
    Quartier P; Rodrigues F; Georgin-Lavialle S
    Rev Med Interne; 2018 Apr; 39(4):287-296. PubMed ID: 29111302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muckle-Wells treatment with anakinra.
    Eungdamrong J; Boyd KP; Meehan SA; Latkowski JA
    Dermatol Online J; 2013 Dec; 19(12):20720. PubMed ID: 24365011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryopyrin-associated periodic syndrome (CAPS) in a patient with NLRP3 T348M mutation.
    Kreft B; Schlinsog AS; Wohlrab J
    J Dtsch Dermatol Ges; 2018 Oct; 16(10):1266-1268. PubMed ID: 30184330
    [No Abstract]   [Full Text] [Related]  

  • 5. Cryopyrin-associated periodic syndrome: an autoinflammatory disease manifested as neutrophilic urticarial dermatosis with additional perieccrine involvement.
    Kolivras A; Theunis A; Ferster A; Lipsker D; Sass U; Dussart A; André J
    J Cutan Pathol; 2011 Feb; 38(2):202-8. PubMed ID: 21062341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief Report: Late-Onset Cryopyrin-Associated Periodic Syndrome Due to Myeloid-Restricted Somatic NLRP3 Mosaicism.
    Mensa-Vilaro A; Teresa Bosque M; Magri G; Honda Y; Martínez-Banaclocha H; Casorran-Berges M; Sintes J; González-Roca E; Ruiz-Ortiz E; Heike T; Martínez-Garcia JJ; Baroja-Mazo A; Cerutti A; Nishikomori R; Yagüe J; Pelegrín P; Delgado-Beltran C; Aróstegui JI
    Arthritis Rheumatol; 2016 Dec; 68(12):3035-3041. PubMed ID: 27273849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
    Landmann EC; Walker UA
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic urticaria in infants as the first manifestation of autoinflammatory disease.
    Latour I; Noguera-Morel L; Colmenero I; Clemente D; Hernández-Martín A; López-Robledillo JC; Arostegui JI; Torrelo A
    Pediatr Dermatol; 2018 Nov; 35(6):e337-e340. PubMed ID: 30168189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe cryopyrin-associated periodic syndrome first characterized by early childhood-onset sensorineural hearing loss - Case report and literature review.
    Hui A; Johnson LB; Greemberg R; Penney L; Ramsey SE
    Int J Pediatr Otorhinolaryngol; 2019 May; 120():68-72. PubMed ID: 30772614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anakinra for cryopyrin-associated periodic syndrome.
    Koné-Paut I; Galeotti C
    Expert Rev Clin Immunol; 2014 Jan; 10(1):7-18. PubMed ID: 24308832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryopyrin-associated periodic syndromes: diagnosis and management.
    Miyamae T
    Paediatr Drugs; 2012 Apr; 14(2):109-17. PubMed ID: 22335455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of cryopyrin-associated periodic fever syndrome as chronic, afebrile urticaria in a 12-month-old female.
    Fitzgerald LA; Drissi M; Sepulveda K; Hovland C; Hendrick SJ; Dubrocq G
    Pediatr Dermatol; 2023; 40(3):532-533. PubMed ID: 36382474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal treatment of CINCA syndrome.
    Paccaud Y; Berthet G; Von Scheven-Gête A; Vaudaux B; Mivelaz Y; Hofer M; Roth-Kleiner M
    Pediatr Rheumatol Online J; 2014; 12():52. PubMed ID: 25584041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urticaria, fever, and hypofibrinogenemia.
    Mohr V; Schulz A; Lohse P; Schumann C; Debatin KM; Schuetz C
    Arthritis Rheumatol; 2014 May; 66(5):1377. PubMed ID: 24782193
    [No Abstract]   [Full Text] [Related]  

  • 15. Cryopyrin-associated periodic syndrome in early childhood can be successfully treated with interleukin-1 blockades.
    Eskola V; Pohjankoski H; Kröger L; Aalto K; Latva K; Korppi M
    Acta Paediatr; 2018 Apr; 107(4):577-580. PubMed ID: 29331074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muckle-Wells Syndrome: A Case Report with an NLRP3 T348M Mutation.
    Naz Villalba E; Gomez de la Fuente E; Caro Gutierrez D; Pinedo Moraleda F; Yanguela Rodilla J; Mazagatos Angulo D; López Estebaranz JL
    Pediatr Dermatol; 2016 Sep; 33(5):e311-4. PubMed ID: 27435956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muckle-Wells syndrome without mutation in exon 3 of the NLRP3 gene, identified by evidence of excessive monocyte production of functional interleukin 1β and rapid response to anakinra.
    Sabroe RA; Stokes CA; Parker LC; Higgins K; Prince LR; Sabroe I
    Clin Exp Dermatol; 2013 Dec; 38(8):874-7. PubMed ID: 23889084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation in the CIAS1/NLRP3 gene associated with an unexpected phenotype of cryopyrin-associated periodic syndromes.
    Insalaco A; Prencipe G; Buonuomo PS; Ceccherini I; Bracaglia C; Pardeo M; Nicolai R; De Benedetti F
    Clin Exp Rheumatol; 2014; 32(1):123-5. PubMed ID: 24144430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryopyrin-associated periodic syndrome.
    Posch C; Kaulfersch W; Rappersberger K
    Pediatr Dermatol; 2014; 31(2):228-31. PubMed ID: 22891689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of neonatal onset multisystem inflammatory disease supporting a role of interleukin-1β in moyamoya syndrome.
    Wohlrab F; Bauknecht C; Meisel C; Dreier JP
    Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):e1-3. PubMed ID: 33109682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.